表紙
市場調查報告書
商品編碼
1028887

HER2抑制劑的全球市場 (2021年) - COVID-19造成的成長和變化 (2030年)

HER2 Inhibitors Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球HER2抑制劑市場相關調查分析,提供市場特徵,市場規模與成長率,市場區隔,各地區·各國明細,競爭情形,市場佔有率,趨勢與策略相關的系統性資訊。

目錄

第1章 摘要整理

第2章 HER2抑制劑市場特徵

第3章 HER2抑制劑市場趨勢與策略

第4章 COVID-19對HER2抑制劑的影響

第5章 HER2抑制劑的市場規模與成長率

  • 全球HER2抑制劑市場實際成果 (金額)
  • 全球HER2抑制劑市場預測 (金額)

第6章 HER2抑制劑市場區隔

  • 全球HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 單劑療法
  • 聯合治療
  • 全球HER2抑制劑市場:各適應症,實際成果與預測 (金額)
  • 扁平表皮癌症
  • 腺癌症
  • 大細胞癌症
  • 乳癌
  • 其他
  • 全球HER2抑制劑市場:各終端用戶,實際成果與預測 (金額)
  • 醫院
  • 診所
  • 其他

第7章 HER2抑制劑市場各地區·各國分析

  • 全球HER2抑制劑市場:各地區,實際成果與預測 (金額)
  • 全球HER2抑制劑市場:各國,實際成果與預測 (金額)

第8章 亞太地區的HER2抑制劑市場

  • 亞太地區的HER2抑制劑市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府的積極推動,法規,法規機關,主要的協會,課稅,公司稅結構,投資,主要企業
  • 亞太地區的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 亞太地區的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第9章 中國的HER2抑制劑市場

  • 中國的HER2抑制劑市場概要
  • 中國的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 中國的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第10章 印度的HER2抑制劑市場

  • 印度的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 印度的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第11章 日本的HER2抑制劑市場

  • 日本的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 日本的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第12章 澳洲的HER2抑制劑市場

  • 澳洲的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 澳洲的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第13章 印尼的HER2抑制劑市場

  • 印尼的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 印尼的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第14章 韓國的HER2抑制劑市場

  • 韓國的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 韓國的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第15章 西歐的HER2抑制劑市場

  • 西歐的HER2抑制劑市場概要
  • 西歐的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 西歐的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第16章 英國的HER2抑制劑市場

  • 英國的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 英國的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第17章 德國的HER2抑制劑市場

  • 德國的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 德國的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第18章 法國的HER2抑制劑市場

  • 法國的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 法國的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第19章 東歐的HER2抑制劑市場

  • 東歐的HER2抑制劑市場概要
  • 東歐的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 東歐的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第20章 俄羅斯的HER2抑制劑市場

  • 俄羅斯的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 俄羅斯的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第21章 北美的HER2抑制劑市場

  • 北美的HER2抑制劑市場概要
  • 北美的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 北美的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第22章 美國的HER2抑制劑市場

  • 美國的HER2抑制劑市場概要
  • 美國的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 美國的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第23章 南美的HER2抑制劑市場

  • 南美的HER2抑制劑市場概要
  • 南美的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 南美的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第24章 巴西的HER2抑制劑市場

  • 巴西的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 巴西的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第25章 中東的HER2抑制劑市場

  • 中東的HER2抑制劑市場概要
  • 中東的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 中東的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第26章 非洲的HER2抑制劑市場

  • 非洲的HER2抑制劑市場概要
  • 非洲的HER2抑制劑市場:不同治療,實際成果與預測 (金額)
  • 非洲的HER2抑制劑市場:各適應症,實際成果與預測 (金額)

第27章 HER2抑制劑市場競爭情形和企業簡介

  • HER2抑制劑市場競爭情形
  • HER2抑制劑市場企業簡介
    • F. Hoffmann-La Roche Ltd.
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Puma Biotechnology Inc.

第28章 HER2抑制劑的開發平台分析

第29章 HER2抑制劑市場上主要的收購與合併

第30章 HER2抑制劑市場未來發展預測與潛在性分析

第31章 附錄

目錄
Product Code: h911

HER2 Inhibitors Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global HER2 inhibitors market market.

This report focuses on HER2 inhibitors market market which is experiencing strong growth. The report gives a guide to the HER2 inhibitors market market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the HER2 inhibitors market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The HER2 Inhibitors Market market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider HER2 inhibitors market market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The HER2 inhibitors market market section of the report gives context. It compares the HER2 inhibitors market market with other segments of the HER2 inhibitors market market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, HER2 inhibitors market indicators comparison.

Scope

Markets Covered: 1) By Treatment: Monotherapy; Combination Therapy

2) By Application: Squamous Cell Carcinoma; Adenocarcinoma; Large Cell Carcinoma; Breast Cancer; Others

3) By End User: Hospitals; Clinics; Others

Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Puma Biotechnology, Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. HER2 Inhibitors Market Characteristics

3. HER2 Inhibitors Market Trends And Strategies

4. Impact Of COVID-19 On HER2 Inhibitors

5. HER2 Inhibitors Market Size And Growth

  • 5.1. Global HER2 Inhibitors Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global HER2 Inhibitors Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. HER2 Inhibitors Market Segmentation

  • 6.1. Global HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Monotherapy
  • Combination Therapy
  • 6.2. Global HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Squamous Cell Carcinoma
  • Adenocarcinoma
  • Large Cell Carcinoma
  • Breast Cancer
  • Others
  • 6.3. Global HER2 Inhibitors Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Clinics
  • Others

7. HER2 Inhibitors Market Regional And Country Analysis

  • 7.1. Global HER2 Inhibitors Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global HER2 Inhibitors Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific HER2 Inhibitors Market

  • 8.1. Asia-Pacific HER2 Inhibitors Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China HER2 Inhibitors Market

  • 9.1. China HER2 Inhibitors Market Overview
  • 9.2. China HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India HER2 Inhibitors Market

  • 10.1. India HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan HER2 Inhibitors Market

  • 11.1. Japan HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia HER2 Inhibitors Market

  • 12.1. Australia HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia HER2 Inhibitors Market

  • 13.1. Indonesia HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea HER2 Inhibitors Market

  • 14.1. South Korea HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe HER2 Inhibitors Market

  • 15.1. Western Europe HER2 Inhibitors Market Overview
  • 15.2. Western Europe HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK HER2 Inhibitors Market

  • 16.1. UK HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany HER2 Inhibitors Market

  • 17.1. Germany HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France HER2 Inhibitors Market

  • 18.4. France HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe HER2 Inhibitors Market

  • 19.1. Eastern Europe HER2 Inhibitors Market Overview
  • 19.2. Eastern Europe HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia HER2 Inhibitors Market

  • 20.1. Russia HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America HER2 Inhibitors Market

  • 21.1. North America HER2 Inhibitors Market Overview
  • 21.2. North America HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA HER2 Inhibitors Market

  • 22.1. USA HER2 Inhibitors Market Overview
  • 22.2. USA HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America HER2 Inhibitors Market

  • 23.1. South America HER2 Inhibitors Market Overview
  • 23.2. South America HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil HER2 Inhibitors Market

  • 24.1. Brazil HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East HER2 Inhibitors Market

  • 25.1. Middle East HER2 Inhibitors Market Overview
  • 25.2. Middle East HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa HER2 Inhibitors Market

  • 26.1. Africa HER2 Inhibitors Market Overview
  • 26.2. Africa HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. HER2 Inhibitors Market Competitive Landscape And Company Profiles

  • 27.1. HER2 Inhibitors Market Competitive Landscape
  • 27.2. HER2 Inhibitors Market Company Profiles
    • 27.2.1. F. Hoffmann-La Roche Ltd.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Merck & Co. Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Novartis AG
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Pfizer Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Puma Biotechnology Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. HER2 Inhibitors Pipeline Analysis

29. Key Mergers And Acquisitions In The HER2 Inhibitors Market

30. HER2 Inhibitors Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer